[go: up one dir, main page]

NO20090646L - Xinafoatsalt av en substituert 5-oksazol-2-yl-kinolinforbindelse - Google Patents

Xinafoatsalt av en substituert 5-oksazol-2-yl-kinolinforbindelse

Info

Publication number
NO20090646L
NO20090646L NO20090646A NO20090646A NO20090646L NO 20090646 L NO20090646 L NO 20090646L NO 20090646 A NO20090646 A NO 20090646A NO 20090646 A NO20090646 A NO 20090646A NO 20090646 L NO20090646 L NO 20090646L
Authority
NO
Norway
Prior art keywords
oxazol
substituted
quinoline compound
xinafoate salt
compound
Prior art date
Application number
NO20090646A
Other languages
English (en)
Inventor
Pauline C Ting
Michael R Reeder
Joe F Lee
Kung I Feng
Scott T Trzaska
Man Zhu
Chen Mao
Dimitar L Filipov
Dimitrios Zarkadas
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20090646L publication Critical patent/NO20090646L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Foreliggende oppfinnelse gjelder forbindelsen med formel (I) fremgangsmåter for behandling av obstruktive sykdommer i de øvre eller nedre luftveier ved anvendelse av forbindelsen, preparater som omfatter forbindelsen og polymorfe former og fremgangsmåter for syntese av de polymorfe formene.
NO20090646A 2006-07-11 2009-02-10 Xinafoatsalt av en substituert 5-oksazol-2-yl-kinolinforbindelse NO20090646L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83005706P 2006-07-11 2006-07-11
PCT/US2007/015715 WO2008008327A2 (en) 2006-07-11 2007-07-10 Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound

Publications (1)

Publication Number Publication Date
NO20090646L true NO20090646L (no) 2009-04-07

Family

ID=38895717

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090646A NO20090646L (no) 2006-07-11 2009-02-10 Xinafoatsalt av en substituert 5-oksazol-2-yl-kinolinforbindelse

Country Status (22)

Country Link
US (1) US7919505B2 (no)
EP (1) EP2038277A2 (no)
JP (2) JP5097774B2 (no)
KR (1) KR20090026217A (no)
CN (1) CN101547920B (no)
AR (1) AR061890A1 (no)
AU (1) AU2007273007B2 (no)
BR (1) BRPI0712915A2 (no)
CA (1) CA2657902A1 (no)
CL (1) CL2007002020A1 (no)
CO (1) CO6190533A2 (no)
EC (1) ECSP099045A (no)
IL (1) IL196402A0 (no)
MX (1) MX2009000460A (no)
NO (1) NO20090646L (no)
NZ (1) NZ574070A (no)
PE (2) PE20080550A1 (no)
RU (1) RU2009104346A (no)
SG (1) SG173366A1 (no)
TW (1) TW200813040A (no)
WO (1) WO2008008327A2 (no)
ZA (1) ZA200900208B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005116009A1 (en) * 2004-05-18 2005-12-08 Schering Corporation Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors
AU2007284688A1 (en) * 2006-08-14 2008-02-21 Schering Corporation Process and intermediates for the synthesis of 2-(Quinolin-5-yl)-4,5 Disubstituted-Azole derivatives
JP2010533175A (ja) * 2007-07-10 2010-10-21 シェーリング コーポレイション 置換５−オキサゾール−２−イル−キノリン化合物の塩酸塩およびその生成方法
CA2692781A1 (en) * 2007-07-10 2009-01-15 Schering Corporation Process for the production of substituted 5-quinolyl-oxazoles and pharmaceutically acceptable salts thereof
JP5709101B2 (ja) * 2010-09-01 2015-04-30 東レ・ファインケミカル株式会社 ヒドロキシプロリン誘導体の製造法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2600644B2 (ja) * 1991-08-16 1997-04-16 藤沢薬品工業株式会社 チアゾリルベンゾフラン誘導体
US5352707A (en) * 1992-03-26 1994-10-04 Harbor Branch Oceanographic Institution, Inc. Method for treating airway congestion
US5270324A (en) * 1992-04-10 1993-12-14 Merck Frosst Canada, Inc. Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
US5472964A (en) * 1992-12-22 1995-12-05 Merck Frosst Canada, Inc. Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
KR20000065219A (ko) * 1996-05-20 2000-11-06 마르크 젠너 티엔에프 저해제 및 피디이-4 저해제로서의 퀴놀린 카르복사미드
EP0912519A1 (en) * 1996-05-20 1999-05-06 Darwin Discovery Limited Quinoline sulfonamides as tnf inhibitors and as pde-iv inhibitors
US6069151A (en) * 1996-11-06 2000-05-30 Darwin Discovery, Ltd. Quinolines and their therapeutic use
US20050017134A1 (en) * 2003-07-24 2005-01-27 Hooper Patricia E. Glass and bottle holders
WO2005116009A1 (en) 2004-05-18 2005-12-08 Schering Corporation Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors
EP2484382A1 (en) * 2005-03-30 2012-08-08 Schering Corporation Medicament comprising a phosphodiesterase IV inhibitor in an inhalable form

Also Published As

Publication number Publication date
NZ574070A (en) 2011-12-22
MX2009000460A (es) 2009-01-27
PE20110391A1 (es) 2011-06-22
EP2038277A2 (en) 2009-03-25
ECSP099045A (es) 2009-02-27
ZA200900208B (en) 2010-01-27
IL196402A0 (en) 2009-09-22
BRPI0712915A2 (pt) 2012-10-09
CN101547920A (zh) 2009-09-30
WO2008008327A3 (en) 2008-03-06
KR20090026217A (ko) 2009-03-11
US20080027101A1 (en) 2008-01-31
AU2007273007B2 (en) 2012-11-01
CN101547920B (zh) 2012-06-27
TW200813040A (en) 2008-03-16
PE20080550A1 (es) 2008-06-13
AR061890A1 (es) 2008-10-01
WO2008008327A2 (en) 2008-01-17
JP2012214482A (ja) 2012-11-08
SG173366A1 (en) 2011-08-29
CL2007002020A1 (es) 2008-02-22
RU2009104346A (ru) 2010-08-20
CA2657902A1 (en) 2008-01-17
JP2009542811A (ja) 2009-12-03
JP5097774B2 (ja) 2012-12-12
CO6190533A2 (es) 2010-08-19
AU2007273007A1 (en) 2008-01-17
US7919505B2 (en) 2011-04-05

Similar Documents

Publication Publication Date Title
NO20084005L (no) Aminderivater
NO20090755L (no) Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
TW200833675A (en) Nicotinamide derivatives
UA96961C2 (uk) Азаадамантанові похідні і способи застосування
WO2006113919A3 (en) Aryl alkyl acid derivatives for and use thereof
WO2008019967A3 (en) Phenyl, pyridine and quinoline derivatives
WO2010014836A3 (en) Tgr5 modulators and methods of use thereof
WO2007138282A3 (en) Bi-aryl or aryl-heteroaryl substituted indoles
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
MX2010009752A (es) Compuestos de oxadiazoantraceno para el tratamiento de diabetes.
TW200734311A (en) New compounds
EA201000050A1 (ru) Замещенные бициклолактамные соединения
NO20080865L (no) Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer
NO20090166L (no) Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
WO2008086226A8 (en) Factor xa inhibitors
WO2009121033A3 (en) Substituted nitrogen heterocycles and synthesis and uses thereof
WO2008059370A8 (en) Substituted bicyclocarboxyamide compounds
ATE520651T1 (de) Substituierte phenylmethylbicyclocarbonsäureamidverbindungen
WO2009025785A3 (en) Cb2 receptor ligands for the treatment of pain
EA201190293A1 (ru) Пролекарства триптолида
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
WO2007079163A3 (en) Prokineticin 1 receptor antagonists
NO20090646L (no) Xinafoatsalt av en substituert 5-oksazol-2-yl-kinolinforbindelse
WO2008088727A3 (en) Endothelin receptor antagonists

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application